Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Drug-Resistant H. Pylori Eradication
NCT03142620Phase 3Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- Mar 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vitamin d in Helicobacter pylori infection (3 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Eradication status of H. pylori infection at Week 4. Status: unknown.
02
Drugs
vitamin d
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03142620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03142620.